🇺🇸 FDA
Pipeline program

ONDANSETRON, IRINOTECAN, CALCIUM FOLINATE, CALCIUM LEVOFOLINATE, FLUOROURACIL, METHYLPREDNISOLONE

APHP220917

Phase 3 small_molecule active

Quick answer

ONDANSETRON, IRINOTECAN, CALCIUM FOLINATE, CALCIUM LEVOFOLINATE, FLUOROURACIL, METHYLPREDNISOLONE for patient with colorectal cancer with hepatic metastasis is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
patient with colorectal cancer with hepatic metastasis
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials